Specifically, a dose of 400 mg × 2/day of CurQfen® attenuates AD progression and improves locomotor and cognitive functions by upregulating BDNF levels and downregulating IL-6 and TNF-α cytokines in patients with moderate dementia after 6 months [141]. Here, IL6 is linked to Alzheimer disease.